Deep Blue Medical Advances closes an oversubscribed $5.6M Series A round to support the launch of its T-Line® Mesh and expansion into aesthetic applications.
Amount Raised
$5.6 Million
Round Type
Series A
Description
Deep Blue Medical Advances, a surgical device company, has closed a $5.6 million Series A financing round. The funding will support the commercial launch of their T-Line® Mesh and facilitate expansion into new applications. CEO Bill Perry expressed strong investor confidence in their platform backed by extensive clinical evidence. Lou Fuqua has been promoted to COO to lead the company's growth phase.
Quick answer
Deep Blue Medical Advances raised $5.6 Million in a Series A round, dated April 21, 2026. Deep Blue Medical Advances is based in Durham, North Carolina, United States.
- How much did Deep Blue Medical Advances raise?
- Deep Blue Medical Advances raised $5.6 Million in a Series A round on April 21, 2026.
- What does Deep Blue Medical Advances do?
- Deep Blue Medical Advances, a Duke University spin-out, is transforming hernia repair with its surgeon-invented T-Line® Hernia Mesh, designed to address the high global rates of hernia occurrence and recurrence.
- Where is Deep Blue Medical Advances based and how big is it?
- Deep Blue Medical Advances is based in Durham, North Carolina, United States. Fundz records about 11 employees.
- Who are the decision-makers at Deep Blue Medical Advances?
- Fundz holds 2 contacts at Deep Blue Medical Advances, including the Director of Research Development. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Consumer Goods and medical devices around the same time
Companies in the same sectors as Deep Blue Medical Advances that raised within 45 days of this round, from Fundz verified event records.
- Patina raised $2M (Seed) on May 22, 2026.
- Endovascular Engineering raised $80M (Series C) on April 7, 2026.
- Venus Concept Inc. raised $1.5M on March 26, 2026.
- IceCure Medical raised $4M on March 26, 2026.
- Innovafeed raised $59M (Series D) on June 5, 2026.
- Flourish raised $500M (Funding Round) on June 5, 2026.
Who to call at Deep Blue Medical Advances, and when
A new round usually means Deep Blue Medical Advances is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Deep Blue Medical Advances raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Deep Blue Medical Advances, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Deep Blue Medical Advances. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Deep Blue Medical Advances raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansDeep Blue Medical Advances raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.